New Publication: Reaksi Drug Safety News - Issue 4/2017 Cetak Kadar pengguna: 1 / 5 Sila beri kadar Undi 1 Undi 2 Undi 3 Undi 4 Undi 5 REAKSI Drug Safety News, Issue 4/2017, Vol. 36 Hyoscine Butylbromide Injection: Risk of Serious Adverse Effects in Patients with Underlying Cardiac Disease Keytruda® (pembrolizumab): Risk of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) DOWNLOAD PDF